Vestcor Inc’s Cidara Therapeutics CDTX Stock Holding History

Vestcor Inc’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,000	Closed	-$5.52M	–	1208
2025 Q4	$5.52M	Buy	+25,000	New	+$4.04M	0.16%	151

Vestcor Inc's CDTX Position: Q1 2026 in Review

Vestcor Inc sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 25,000 shares — an estimated $5.52M sold.

Vestcor Inc first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $5.52M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Vestcor Inc reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Vestcor Inc sold 25,000 Cidara Therapeutics shares in Q1 2026, an estimated $5.52M.
Vestcor Inc first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Vestcor Inc's Cidara Therapeutics position peaked at $5.52M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.